menu
    • menu

    Company profile for Oramed Pharmaceuticals

    NEW Drugs in Dev: 7
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    CLINICAL TRIALS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Oramed Pharmaceuticals (NASDAQ: ORMP) was established in 2006, and has developed a unique proprietary platform technology that allows for the oral delivery of drugs presently administered only via injection. Oramed has an experienced management team with many years of business and pharmaceutical experience, and is backed by world-class scientific experts. From the company’s inception, Oramed has successfully tested its...
    Oramed Pharmaceuticals (NASDAQ: ORMP) was established in 2006, and has developed a unique proprietary platform technology that allows for the oral delivery of drugs presently administered only via injection. Oramed has an experienced management team with many years of business and pharmaceutical experience, and is backed by world-class scientific experts. From the company’s inception, Oramed has successfully tested its technology via various animal and human studies on its two flagship products, an orally ingestible insulin capsule, ORMD-0801, and an oral GLP-1 analog (exenatide) capsule, ORMD-0901.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Oramed PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Suite 228, 1185 Avenue of the Americas New York, NY 10036
    Telephone
    Telephone
    +18449ORAMED
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.oramed.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Arab Health

    Arab Health

    Not Confirmed

    envelop Contact Supplier

    Arab Health

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Lifeward Inks Strategic Investment Deal With Oramed
    Lifeward Inks Strategic Investment Deal With Oramed

    13 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/13/3217760/32993/en/Lifeward-Enters-Transformative-Strategic-Investment-and-Partnership-Agreement-with-Oramed-to-Create-a-Diversified-Biomedical-Innovation-Company.html

    GLOBENEWSWIRE
    13 Jan 2026
    Share Share
    Oramed Receives $18 Million Payment from Scilex Holdings
    Oramed Receives $18 Million Payment from Scilex Holdings

    07 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/oramed-receives-18-million-payment-from-scilex-holdings-bringing-current-returns-to-118-million-board-approves-dividend-payments-302655143.html

    PR NEWSWIRE
    07 Jan 2026
    Share Share
    Oramed Pharma Announces Common Stock Purchase Rights Dividend
    Oramed Pharma Announces Common Stock Purchase Rights Dividend

    17 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/oramed-pharmaceuticals-inc-declares-dividend-distribution-of-common-stock-purchase-rights-302617147.html

    PR NEWSWIRE
    17 Nov 2025
    Share Share
    Oramed Reports Fiscal Third Quarter 2025 Financial Results
    Oramed Reports Fiscal Third Quarter 2025 Financial Results

    17 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/oramed-reports-fiscal-third-quarter-2025-financial-results-302617174.html

    PR NEWSWIRE
    17 Nov 2025
    Share Share
    Oramed Highlights Oral Insulin Progress, Investment Growth
    Oramed Highlights Oral Insulin Progress, Investment Growth

    23 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/oramed-releases-letter-to-shareholders-highlighting-developments-in-its-oral-insulin-program-significant-investment-appreciation-and-upcoming-growth-initiatives-302592812.html

    PR NEWSWIRE
    23 Oct 2025
    Share Share
    Scilex Completes First Tranche Of Oramed Pharma Warrant
    Scilex Completes First Tranche Of Oramed Pharma Warrant

    01 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/01/3159560/0/en/Scilex-Holding-Company-Announces-the-Completion-of-the-First-Tranche-of-the-Oramed-Pharmaceuticals-Inc-Warrant-Repurchase.html

    GLOBENEWSWIRE
    01 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search